KEYSTONE BIO

Serial Number 90529237
606

Registration Progress

Application Filed
Feb 15, 2021
Under Examination
May 16, 2023
Approved for Publication
Mar 21, 2023
Published for Opposition
Mar 21, 2023
Registered

Trademark Image

KEYSTONE BIO

Basic Information

Serial Number
90529237
Filing Date
February 15, 2021
Published for Opposition
March 21, 2023
Abandonment Date
December 16, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 16, 2024
Classes
005

Rights Holder

Keystone Bio, Inc.

03
Address
1750 Frontenac Woods Ln.
St. Louis, MO 63131

Ownership History

Keystone Bio, Inc.

Original Applicant
03
St. Louis, MO

Keystone Bio, Inc.

Owner at Publication
03
St. Louis, MO

Legal Representation

Attorney
Tara L. Allstun

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

29 events
Date Code Type Description
Dec 16, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 16, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
May 17, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 16, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
May 16, 2024 EXT2 S SOU EXTENSION 2 FILED
May 16, 2024 EX2G S SOU EXTENSION 2 GRANTED
Oct 19, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 17, 2023 EX1G S SOU EXTENSION 1 GRANTED
Oct 17, 2023 EXT1 S SOU EXTENSION 1 FILED
Oct 17, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
May 16, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 21, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 21, 2023 PUBO A PUBLISHED FOR OPPOSITION
Mar 1, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 13, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 31, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 26, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 26, 2021 GNSL S LETTER OF SUSPENSION E-MAILED
Oct 26, 2021 CNSL R SUSPENSION LETTER WRITTEN
Oct 4, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2021 GNRT F NON-FINAL ACTION E-MAILED
Sep 14, 2021 CNRT R NON-FINAL ACTION WRITTEN
Sep 10, 2021 DOCK D ASSIGNED TO EXAMINER
May 18, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for treatment of neurological and cardiovascular diseases

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"